| 6P5M: Discovery Of A Novel, Highly Potent, And Selective Thieno[3, D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moi 931) As An Orally Active Investigational Anti-Tumor Agent |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).